Charles Feldman to Pneumonia, Pneumococcal
This is a "connection" page, showing publications Charles Feldman has written about Pneumonia, Pneumococcal.
Connection Strength
9,853
-
The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy. Int J Mol Sci. 2023 Jul 03; 24(13).
Score: 0,805
-
Serotype-specific Cardiac Involvement in Pneumococcal Pneumonia. Clin Infect Dis. 2022 02 11; 74(3):507-508.
Score: 0,731
-
A case for implementation of adult pneumococcal vaccine program in Africa: review and expert opinion. Pan Afr Med J. 2022; 41:51.
Score: 0,728
-
Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia. Front Immunol. 2020; 11:577303.
Score: 0,663
-
Pneumococcal virulence factors in community-acquired pneumonia. Curr Opin Pulm Med. 2020 05; 26(3):222-231.
Score: 0,646
-
Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia. J Intern Med. 2019 06; 285(6):635-652.
Score: 0,592
-
Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia. Int J Mol Sci. 2018 Apr 11; 19(4).
Score: 0,560
-
Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia. J Infect. 2017 12; 75(6):473-485.
Score: 0,539
-
Pneumolysin as a potential therapeutic target in severe pneumococcal disease. J Infect. 2017 06; 74(6):527-544.
Score: 0,520
-
The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia. Semin Respir Crit Care Med. 2016 12; 37(6):806-818.
Score: 0,511
-
Bacteraemic pneumococcal pneumonia: current therapeutic options. Drugs. 2011 Jan 22; 71(2):131-53.
Score: 0,340
-
Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics. Int J Antimicrob Agents. 2010 Jul; 36(1):95-7.
Score: 0,322
-
Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care. Clin Microbiol Infect. 2009 Sep; 15(9):850-7.
Score: 0,309
-
Bacteraemic pneumococcal pneumonia: impact of HIV on clinical presentation and outcome. J Infect. 2007 Aug; 55(2):125-35.
Score: 0,264
-
Controversies in the treatment of pneumococcal community-acquired pneumonia. Future Microbiol. 2006 Oct; 1(3):271-81.
Score: 0,252
-
Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Arch Immunol Ther Exp (Warsz). 2005 May-Jun; 53(3):189-98.
Score: 0,228
-
Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J. 2005 Apr; 25(4):688-92.
Score: 0,227
-
Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin. Respir Med. 2004 Aug; 98(8):708-20.
Score: 0,217
-
CD4 T-lymphocyte subset counts in HIV-seropositive patients during the course of community-acquired pneumonia caused by Streptococcus pneumoniae. Clin Microbiol Infect. 2004 Jun; 10(6):587-9.
Score: 0,214
-
Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med. 2004 May; 143(5):269-83.
Score: 0,213
-
Dual infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in HIV-seropositive patients with community acquired pneumonia. Int J Tuberc Lung Dis. 2003 Dec; 7(12):1207-8.
Score: 0,207
-
Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults. Chest. 1999 Jul; 116(1):107-14.
Score: 0,152
-
Antibiotic-resistant pneumococcal pneumonia. S Afr Med J. 1996 Jan; 86(1):28-30.
Score: 0,120
-
Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm. 2013; 2013:490346.
Score: 0,104
-
Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration. 1991; 58(5-6):265-70.
Score: 0,085
-
Initial hormonal and metabolic profile in critically ill patients with community-acquired lobar pneumonia. S Afr Med J. 1989 Dec 02; 76(11):593-6.
Score: 0,078
-
Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a "severity of illness" core. Intensive Care Med. 1989; 15(5):302-7.
Score: 0,074
-
Community-acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med. 1985 Sep 05; 313(10):615-7.
Score: 0,059
-
Streptococcus pneumoniae respiratory tract infections. Curr Opin Infect Dis. 2001 Apr; 14(2):173-9.
Score: 0,043
-
A study of acute community-acquired pneumonia, including details of cardiac changes. Q J Med. 1993 Oct; 86(10):669-75.
Score: 0,026
-
Effect of immunization with Freund's adjuvant and pneumolysin on histologic features of pneumococcal infection in the rat lung in vivo. Infect Immun. 1992 Nov; 60(11):4969-72.
Score: 0,024